234 related articles for article (PubMed ID: 21844575)
1. Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey.
Kilic A; Aktas Z; Bedir O; Gumral R; Bulut Y; Stratton C; Tang YW; Basustaoglu AC
Ann Clin Lab Sci; 2011; 41(2):161-6. PubMed ID: 21844575
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
5. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
Chia JH; Chu C; Su LH; Chiu CH; Kuo AJ; Sun CF; Wu TL
J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey.
Aktaş Z; Kayacan CB; Schneider I; Can B; Midilli K; Bauernfeind A
Chemotherapy; 2008; 54(2):101-6. PubMed ID: 18303258
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
8. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
9. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
[TBL] [Abstract][Full Text] [Related]
10. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
Oktem IM; Gulay Z; Bicmen M; Gur D;
Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
12. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Ensor VM; Shahid M; Evans JT; Hawkey PM
J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
[TBL] [Abstract][Full Text] [Related]
13. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
Potron A; Rondinaud E; Poirel L; Belmonte O; Boyer S; Camiade S; Nordmann P
Int J Antimicrob Agents; 2013 Apr; 41(4):325-9. PubMed ID: 23305656
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland.
Poirel L; Schrenzel J; Cherkaoui A; Bernabeu S; Renzi G; Nordmann P
J Antimicrob Chemother; 2011 Aug; 66(8):1730-3. PubMed ID: 21628303
[TBL] [Abstract][Full Text] [Related]
15. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
16. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
[TBL] [Abstract][Full Text] [Related]
18. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
Ho PL; Cheung YY; Wang Y; Lo WU; Lai EL; Chow KH; Cheng VC
Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):379-85. PubMed ID: 26740321
[TBL] [Abstract][Full Text] [Related]
19. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
[TBL] [Abstract][Full Text] [Related]
20. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
